Autism Spectrum Disorder Trial, Recruiting NCT03217110 Sponsor: Krystal Parker, PhD Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT03217110
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a diagnosis that matches what this trial is studying (confirm with trial site for specific conditions)

Who may not be able to join:

  • You have a history of repeated seizures or epilepsy
  • You have any neurological or psychiatric condition other than the one this trial is specifically studying
  • You have had an active drug or alcohol use problem in the past 6 months (not including tobacco)
  • You are not able to give your own informed consent to take part in the study
  • You have a pacemaker fitted
  • You have a coronary stent (a small tube placed in a heart artery)
  • You have a defibrillator device
  • You have any kind of nerve stimulation device implanted in your body
  • You experience claustrophobia (fear of enclosed spaces)
  • You have high blood pressure that is not well controlled by treatment
  • You have atrial fibrillation (an irregular heartbeat condition)
  • You have significant heart disease
  • You have unstable blood circulation or blood pressure problems (confirm with trial site)
  • You have kidney disease
  • You are pregnant, trying to become pregnant, or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Krystal L Parker, Ph.D, Univeristy of Iowa

Phone: 319-353-4554

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Krystal Parker, PhD
Registry
ClinicalTrials.gov
Start date
30 November 2017
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in disease-specific symptom rating scale, one scale identified for each group (MADRS for bipolar group; PANSS for schizophrenia group; UPDRS in Parkinson's patient group).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov